RelB silencing reversed tamoxifen resistance by regulating GPx4 and ferroptosis in breast cancer

被引：2
|
作者：
Xu, Z. [1 ]
Tang, J. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Dept Gen Surg, Nanjing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.annonc.2020.08.1287
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1981P
引用
收藏
页码：S1111 / S1111
页数：1
相关论文
共 50 条
  • [1] RelB silencing to reverse tamoxifen resistance by regulating GPx4 and ferroptosis in breast cancer.
    Xu, Zhi
    Tang, Jinhai
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
    Xu, Zhi
    Wang, Xiumei
    Sun, Wenbo
    Xu, Fan
    Kou, Hengyuan
    Hu, Weizi
    Zhang, Yanyan
    Jiang, Qin
    Tang, Jinhai
    Xu, Yong
    REDOX BIOLOGY, 2023, 68
  • [3] Honokiol induces ferroptosis in colon cancer cells by regulating GPX4 activity
    Guo, Cao
    Liu, Ping
    Deng, Ganlu
    Han, Ying
    Chen, Yihong
    Cai, Changjing
    Shen, Hong
    Deng, Gongping
    Zeng, Shan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 3039 - 3054
  • [4] GPX4, ferroptosis, and diseases
    Zhang, Wangzheqi
    Liu, Yang
    Liao, Yan
    Zhu, Chenglong
    Zou, Zui
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [5] CircRHOT1 restricts gastric cancer cell ferroptosis by epigenetically regulating GPX4
    Wang, Huan
    Breadner, Daniel Adam
    Deng, Ke
    Niu, Jing
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (04) : 1715 - 1725
  • [6] Simvastatin induces ferroptosis in breast cancer cells by inhibiting GPX4 and sensitizes chemotherapy
    Lu, Sihong
    Shao, Nan
    Bi, Jong
    Lin, Ying
    CANCER RESEARCH, 2021, 81 (04)
  • [7] GPX4 IS A KEY REGULATOR OF FERROPTOSIS
    不详
    CANCER DISCOVERY, 2014, 4 (03) : 269 - 269
  • [8] Angelica sinensis polysaccharide combined with cisplatin reverses cisplatin resistance of ovarian cancer by inducing ferroptosis via regulating GPX4
    Guo, Weikang
    Wang, Wanyue
    Lei, Fei
    Zheng, Ruxin
    Zhao, Xinyao
    Gu, Yuze
    Yang, Mengdi
    Tong, Yunshun
    Wang, Yaoxian
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [9] Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges
    Liu, Jiao
    Tang, Daolin
    Kang, Rui
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (08) : 666 - 670
  • [10] In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis
    Golbashirzadeh, Morteza
    Heidari, Hamid Reza
    Aghamolayi, Ali Asghar
    Fattahi, Yasin
    Talebi, Mehdi
    Khosroushahi, Ahmad Yari
    MEDICAL ONCOLOGY, 2023, 40 (10)
12345